2024-04-04 2025-06-30 false Capium Accounts Production 1.1 15615525 2024-04-04 2025-06-30 15615525 bus:AbridgedAccounts 2024-04-04 2025-06-30 15615525 bus:FRS102 2024-04-04 2025-06-30 15615525 bus:AuditExempt-NoAccountantsReport 2024-04-04 2025-06-30 15615525 bus:SmallCompaniesRegimeForAccounts 2024-04-04 2025-06-30 15615525 bus:PrivateLimitedCompanyLtd 2024-04-04 2025-06-30 15615525 2024-04-04 2025-06-30 15615525 2025-06-30 15615525 bus:RegisteredOffice 2024-04-04 2025-06-30 15615525 core:WithinOneYear 2025-06-30 15615525 core:AfterOneYear 2025-06-30 15615525 1 2024-04-04 2025-06-30 15615525 bus:Director1 2024-04-04 2025-06-30 15615525 bus:Director1 2025-06-30 15615525 bus:Director2 2024-04-04 2025-06-30 15615525 bus:Director2 2025-06-30 15615525 2023-04-04 15615525 bus:LeadAgentIfApplicable 2024-04-04 2025-06-30 15615525 2024-04-03 15615525 core:NetGoodwill 2024-04-04 2025-06-30 15615525 core:NetGoodwill 2025-06-30 15615525 core:NetGoodwill 2024-04-03 15615525 core:CostValuation core:Non-currentFinancialInstruments 2025-06-30 15615525 core:CostValuation core:Non-currentFinancialInstruments 2024-04-03 15615525 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-06-30 15615525 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-06-30 15615525 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-06-30 15615525 core:Non-currentFinancialInstruments 2025-06-30 15615525 core:Non-currentFinancialInstruments 2024-04-03 15615525 core:ShareCapital 2025-06-30 15615525 core:RetainedEarningsAccumulatedLosses 2025-06-30 15615525 dpl:Item1 2024-04-04 15615525 dpl:Item1 2025-06-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15615525
England and Wales
PROPHARMACE HEALTHCARE LTD
Abridged Accounts
Period of accounts Start date: 04 April 2024 End date: 30 June 2025

PROPHARMACE HEALTHCARE LTD Contents Page For the Period 04 April 2024 to 30 June 2025
Statement of financial position | 1
Notes to the financial statements | 2

PROPHARMACE HEALTHCARE LTD Statement of Financial Position As at 30 June 2025
| Notes | 2025 £
--- | --- | ---
Fixed assets |  |
Intangible fixed assets | 3 | 501,467
|  | 501,467
Current assets |  |
Debtors |  | 100
Net current assets |  | 100
Total assets less current liabilities |  | 501,567
Creditors: amount falling due after more than one year |  | (557,185)
Net assets |  | (55,618)
Capital and reserves |  |
Called up share capital |  | 100
Profit and loss account |  | (55,718)
Shareholders' funds |  | (55,618)
For the period ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 01 January 2026 and were signed on its behalf by:
------------------------------- Modar AL AHMAD Director
1

PROPHARMACE HEALTHCARE LTD Notes to the Abridged Financial Statements For the Period 04 April 2024 to 30 June 2025
General Information PROPHARMACE HEALTHCARE LTD is a private company, limited by shares, registered in England and Wales, registration number 15615525, registration address 47-49 PARK ROYAL ROAD, PREMIER BUSINESS CENTRE LONDON, NW10 7LQ. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Intangible assets Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable. Goodwill Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 10 years.
2. | Average number of employees Average number of employees during the period was 0.
3. | Intangible fixed assets
Cost | Goodwill |  | Total
| £ |  | £
At 04 April 2024 | - |  | -
Additions | 557,185 |  | 557,185
Disposals | - |  | -
At 30 June 2025 | 557,185 |  | 557,185
Amortisation
At 04 April 2024 | - |  | -
Charge for period | 55,718 |  | 55,718
On disposals | - |  | -
At 30 June 2025 | 55,718 |  | 55,718
Net book values
At 30 June 2025 | 501,467 |  | 501,467
At 03 April 2024 | - |  | -
2